Patients with Hepatic Impairment A single-dose, open-label study was conducted to evaluate the pharmacokinetics of QSYMIA 15 mg/92 mg in healthy volunteers with normal hepatic function compared with patients with mild (Child-Pugh score 5 - 6) and moderate (Child-Pugh score 7 - 9) hepatic impairment
Automatic behaviors (same injection day, same meal prep routine, same hydration reminders) continue even when enthusiasm wanes
Thats 0.25 mg of semaglutide, the active ingredient in Ozempic, taken weekly
KEY BENEFITS: ++Reduce hair loss by up to 80% ++Improve hair density, thickness, natural color, and overall hair and scalp health
GLP-1 is released in the body after eating and triggers the release of insulin, which regulates blood sugar